Sign in

CIK 0001531177

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Sight Sciences, Inc.

Sign in to watch
Ticker
SGHT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
800625749
Phone
+1 415-889-0550
Business address
4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$652,777
in 5 filings, $653K under 10b5-1 plans

Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-14 Park Sam Boong Chief Operating Officer Grant or award −151,869 265,168
2024-02-14 Badawi Paul President and CEO Grant or award −390,187 5,763,300
2024-02-14 HAYDEN JEREMY B. Chief Legal Officer Grant or award −151,869 173,513
2024-02-14 Bauerlein Alison Chief Financial Officer Grant or award −315,421 436,371
2024-01-17 Badawi Paul President and CEO Sale −15,917 $5.16 $82K 5,319,539
2024-01-17 Badawi David Chief Technology Officer Sale −3,414 $5.16 $18K 1,642,157
2024-01-17 HAYDEN JEREMY B. Chief Legal Officer Sale −4,538 $5.16 $23K 10,318
2024-01-17 Park Sam Boong Chief Operating Officer Sale −5,443 $5.16 $28K 100,735
2024-01-03 Badawi David Chief Technology Officer Shares withheld for taxes −2,425 $5.17 $13K 1,645,571
2024-01-03 Badawi Paul President and CEO Shares withheld for taxes −8,975 $5.17 $46K 5,335,456
2024-01-03 HAYDEN JEREMY B. Chief Legal Officer Shares withheld for taxes −1,227 $5.17 $6K 14,856
2024-01-03 Park Sam Boong Chief Operating Officer Shares withheld for taxes −2,464 $5.17 $13K 106,178
2023-12-27 D1 Capital Partners L.P. 10% owner Sale −2,852,036 $5.86 $16.7M 3,000,000
2023-11-30 Encrantz Staffan Director Purchase +140,777 $3.46 $487K 1,012,150
2023-11-29 Encrantz Staffan Director Purchase +3,223 $3.50 $11K 871,373
2023-11-28 Encrantz Staffan Director Purchase +253,669 $3.46 $877K 868,150
2023-11-27 Encrantz Staffan Director Purchase +246,331 $3.31 $816K 614,481
2023-11-24 Encrantz Staffan Director Purchase +21,855 $3.09 $67K 368,150
2023-11-24 Badawi David Chief Technology Officer Option exercise +150,000 $0.11 $17K 1,631,196
2023-11-24 Badawi David Chief Technology Officer Option exercise · Stock Option (Right to Buy) −150,000 $0.11 $17K 0

Page 9 of 16 · 302 trades